DD208811A5 - Verfahren zur herstellung von gewebsthromboplastin - Google Patents

Verfahren zur herstellung von gewebsthromboplastin Download PDF

Info

Publication number
DD208811A5
DD208811A5 DD82246077A DD24607782A DD208811A5 DD 208811 A5 DD208811 A5 DD 208811A5 DD 82246077 A DD82246077 A DD 82246077A DD 24607782 A DD24607782 A DD 24607782A DD 208811 A5 DD208811 A5 DD 208811A5
Authority
DD
German Democratic Republic
Prior art keywords
thromboplastin
factor vii
extraction
tissue
calcium
Prior art date
Application number
DD82246077A
Other languages
German (de)
English (en)
Inventor
Udo Becker
Eugen Schaich
Manfred Weigert
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD208811A5 publication Critical patent/DD208811A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/839—Nerves; brain

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Lubricants (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DD82246077A 1981-12-21 1982-12-16 Verfahren zur herstellung von gewebsthromboplastin DD208811A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19813150596 DE3150596A1 (de) 1981-12-21 1981-12-21 Verfahren zur herstellung von gewebsthromboplastin

Publications (1)

Publication Number Publication Date
DD208811A5 true DD208811A5 (de) 1984-04-11

Family

ID=6149306

Family Applications (1)

Application Number Title Priority Date Filing Date
DD82246077A DD208811A5 (de) 1981-12-21 1982-12-16 Verfahren zur herstellung von gewebsthromboplastin

Country Status (11)

Country Link
US (1) US4416812A (da)
EP (1) EP0083773B1 (da)
JP (1) JPS58154515A (da)
AT (1) ATE13447T1 (da)
CA (1) CA1195614A (da)
DD (1) DD208811A5 (da)
DE (2) DE3150596A1 (da)
DK (1) DK158474C (da)
ES (1) ES518420A0 (da)
NO (1) NO160747C (da)
ZA (1) ZA829315B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4928603A (en) * 1984-09-07 1990-05-29 The Trustees Of Columbia University In The City Of New York Method of preparing a cryoprecipitated suspension and use thereof
US4755461A (en) * 1986-04-17 1988-07-05 Bio/Data Corporation Tableted blood plasma microconcentrated thromboplastin coagulation reagent
US5017556A (en) * 1986-11-04 1991-05-21 Genentech, Inc. Treatment of bleeding disorders using lipid-free tissue factor protein
DE3751218T2 (de) * 1986-11-04 1995-11-09 Genentech Inc Verfahren und therapeutische Zubereitungen für die Behandlung von Gerinnungsstörungen.
US5589173A (en) 1986-11-04 1996-12-31 Genentech, Inc. Method and therapeutic compositions for the treatment of myocardial infarction
US5270451A (en) * 1988-11-23 1993-12-14 Baxter Diagnostics Inc. Extraction method for preparing thromboplastin reagents
US5281528A (en) * 1989-12-18 1994-01-25 Warner-Lambert Company Process for purified thromboplastin for ultra-pure thrombin preparation
US5254350A (en) * 1991-07-22 1993-10-19 Helena Laboratories Corporation Method of preparing a thromboplastin extract
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
CA2080428C (en) * 1991-10-22 2004-01-27 Ray F. Ebert A method for preparing a thromboplastin reagent from cultured cells that is suitable for use in the prothrombin time test
US5358853A (en) * 1992-08-03 1994-10-25 Akzo Av Liquid thromboplastin reagent
US5418141A (en) * 1994-05-06 1995-05-23 Avocet Medical, Inc. Test articles for performing dry reagent prothrombin time assays
DE19538716A1 (de) * 1995-10-18 1997-04-24 Behringwerke Ag Verfahren zur Quantifizierung von aktiviertem Gerinnungsfaktor VII (FVIIa)
DE19538715A1 (de) 1995-10-18 1997-04-30 Behringwerke Ag Verfahren zur Reinigung von Faktor VII und aktiviertem Faktor VII
NL1008674C2 (nl) * 1998-03-23 1999-09-24 Harimex Bv Werkwijze voor het bereiden van tromboplastine uit dierlijk weefsel.
JP2002526557A (ja) 1998-10-07 2002-08-20 シグマ−アルドリッチ・カンパニー トロンボプラスチン試薬ならびにそのような試薬の製造および使用方法
US6183979B1 (en) * 1999-03-24 2001-02-06 International Technidyne Corporation Preparation of dried synthetic prothrombin time reagents
JP4526152B2 (ja) * 2000-03-08 2010-08-18 シスメックス株式会社 プロトロンビン時間測定試薬
GB0327094D0 (en) * 2003-11-21 2003-12-24 Inverness Medical Switzerland Laminated device
US7148067B2 (en) * 2004-08-31 2006-12-12 The Board Of Trustees Of The University Of Illinois Thromboplastin reagents
EP1853926A2 (en) * 2005-02-16 2007-11-14 The Board Of Trustees Of The University Of Illinois Procoagulants based on metal-chelating lipids
EP1869082B1 (en) * 2005-03-04 2011-04-13 The Board Of Trustees Of The University Of Illinois Coagulation and fibrinolytic cascades modulator
WO2009046194A2 (en) * 2007-10-05 2009-04-09 The Board Of Trustees Of The University Of Illinois Fibrin sealant
WO2009061697A1 (en) 2007-11-09 2009-05-14 The Board Of Trustees Of The University Of Illinois Anticoagulant antagonist and hemophilia procoagulant
DE102007062323A1 (de) * 2007-12-21 2009-06-25 Siemens Healthcare Diagnostics Products Gmbh Langzeitstabiles Thromboplastin-Reagenz
EP2405274A1 (en) 2010-07-06 2012-01-11 Good biomarker Sciences B.V. Monitoring anticoagulant therapy and identifying reversible direct factor Xa inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2847350A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Preparation of highly active thromboplastin
US2842480A (en) * 1954-05-27 1958-07-08 Ortho Pharma Corp Preparation of thromboplastin
US2847348A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Plasma fractionation and product therefrom
US2921000A (en) * 1956-05-22 1960-01-12 Ortho Pharma Corp Thromboplastin
NL238873A (da) * 1958-05-16
US3228841A (en) * 1965-06-10 1966-01-11 Warner Lambert Pharmaceutical Diagnostic reagent composition for determining blood coagulation factors and method of use
US3522148A (en) * 1965-08-13 1970-07-28 Dade Reagents Inc Stabilized thromboplastin preparation
US3980432A (en) * 1973-04-02 1976-09-14 Behringwerke Aktiengesellschaft Partial thromboplastin, its use as diagnostic agent and process for preparing it
ES431736A1 (es) * 1973-11-13 1977-05-16 Behringwerke Ag Procedimiento para la preparacion de un agente para diagnos-tico para el proposito de efectuar el control de la capaci- dad de coagulacion de la sangre.

Also Published As

Publication number Publication date
NO824279L (no) 1983-06-22
JPS58154515A (ja) 1983-09-14
DK540082A (da) 1983-06-22
ES8402942A1 (es) 1984-03-01
NO160747B (no) 1989-02-13
DE3150596A1 (de) 1983-06-30
EP0083773B1 (de) 1985-05-22
CA1195614A (en) 1985-10-22
NO160747C (no) 1989-05-24
DK158474B (da) 1990-05-21
JPH0339267B2 (da) 1991-06-13
ZA829315B (en) 1983-10-26
ES518420A0 (es) 1984-03-01
DE3263793D1 (en) 1985-06-27
EP0083773A1 (de) 1983-07-20
US4416812A (en) 1983-11-22
DK158474C (da) 1990-10-15
ATE13447T1 (de) 1985-06-15

Similar Documents

Publication Publication Date Title
EP0083773B1 (de) Verfahren zur Herstellung eines Gewebsthromboplastinpräparates
EP0244834B1 (de) Verfahren zur Herstellung eines Faktor V-Konzentrats
DE69033033T2 (de) Verbesserte kontrollverfahren für stabile blutkoagulation
DE2619667C2 (de) Pharmazeutisches Mittel
DE2546166A1 (de) Gegerbte thrombozyten
EP0049877B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin-BM
EP0018353A1 (de) Verfahren zur Herstellung von nebenwirkungsfreien Plasmafraktionen
DE68912115T2 (de) Ausscheidungsverfahren für die herstellung von thromboplastinreagenzien.
EP0120220B1 (de) Verfahren und Reagenz zur Glucosebestimmung im hämolysierten Blut
EP0062310B1 (de) Reagens zur optischen Bestimmung des Blutgerinnungsverhaltens
DE69230209T2 (de) Reagenz zur Blutgerinnung
DE3875854T2 (de) Auf ligninsulfonat aufgebautes pharmazeutisches mittel mit einer atithrombose-aktivitaet.
EP0189910B1 (de) Verfahren zur Bestimmung des fibrinolytischen Zustands von Plasma
DE2361169C3 (de) Verfahren zur Aktivierung von von Detengensspuren befreiter Cholesterinoxydase
DE68912477T3 (de) Verfahren zum messen der biologischen wirkung von antithrombin iii und reagenzkit zu dessen messung
DE2654189C3 (de) Verfahren zur in-vitro-Bestimmung der biologischen Aktivität von Faktor Xa-Inhibitor im Blut
DE69016858T2 (de) Verfahren und Reagenziensatz zur Bestimmung der funktionalen Aktivität von Protein S in menschlichem Plasma.
DE3750344T2 (de) Beschleuniger der Aktivität von Hydrolase.
DE2142343A1 (de) Verfahren zur isolierung thromboplastischen materials
EP0570356B1 (de) Reagens zur Bestimmung der aktivierten partiellen Thromboplastinzeit (aPTT)
EP0570354B1 (de) Verfahren zur Bestimmung von Fibrinogen
EP0020895A1 (de) Partielles Thromboplastin
EP0408075B1 (de) Verfahren und Reagenz zur Bestimmung von Antithrombin III
DE2902657A1 (de) Verfahren zur herstellung von den gerinnungsfaktor ii, v oder viii oder deren gemische enthaltenden konzentraten oder von den faktoren vii, ix, x, xi oder xii oder den gemischen freiem plasma
AT403437B (de) Physiologisch aktive gewebefaktor-präparation

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee